AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com.

ebiobanques.fr is a catalog of the BIOBANQUES network containing information collected from its 96 members and allowing access to 6 millions of biological samples.

EBD Group specializes in bringing people together, whether face-to-face at one of our leading global life science partnering events powered by partneringONE, or virtually through our online community of dealmakers and thought leaders.

The Pharma Logistics Club (PLC) aims to bring together the various players involved in the transport and logistics of health products, often from different backgrounds. PLC encourages free trade, mutual learning and promotes innovative projects.

Since June 2015, we have welcomed more than 900 managers and business leaders belonging either to the Health Industries (laboratories, wholesalers-distributors, custodians, suppliers in clinical research, medical devices) many companies in transport, logistics, metrology, packaging and training.

Technology Transfer Accelerator Offices or SATT are French private TTOs, shared between several public research organizations, created to develop and commercialize research results to be transformed into innovative products. They are part of the measures implemented for the “Investment for the Future” program (PIA), whose ambition is to meet the innovation gap.

SATTs have been created as the cooperation between the public research and the private sector has been identified as key for economic competitiveness.

In France, SATTs have the challenging mission to accelerate the transformation of French research into innovations. Their aim is to enhance the value and to accelerate the process of technology transfer from publically funded research toward industry. SATTs evaluate, market and license technology from French Universities and Public Research Organisations.

SATTs bring their expertise and resources in the IP and maturation process and the transfer of technologies. They are the bridge between the inventive stage of technology and the needs of industry. Bringing together professionalism, expertise and financing, SATTs come along the transfer chain according to the needs of industry. By increasing the Technology Readiness Levels, they also participate in reducing company risks.